NASDAQ: AZRX

SEARCH

SIGN UP

AzurRx Logo
  • About
      • Back
      • Company Profile
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
  • Science & Technology
      • Back
      • Overview
      • Programs
      • Development Pipeline
      • Cystic Fibrosis
      • Chronic Pancreatitis
      • Immune Checkpoint Inhibitor Colitis
      • COVID-19 GI Infections
      • Non-Systemic Biologics
      • Digestive Enzymes
      • Niclosamide
  • Investors
      • Back
      • Press Releases
          • Back
          • 2021
          • 2020
          • 2019
          • 2018
          • 2017
          • 2016
          • 2015
          • 2014
      • Events
      • Presentations
      • Regulatory Filings
      • Financial Statements
          • Back
          • 2020
              • Back
              • Q2 2020
              • Q1 2020
          • 2019
              • Back
              • Q4 2019
              • Q3 2019
              • Q2 2019
              • Q1 2019
          • 2018
              • Back
              • Q4 2018
              • Q3 2018
              • Q2 2018
              • Q1 2018
          • 2017
              • Back
              • Q4 2017
              • Q3 2017
              • Q2 2017
              • Q1 2017
          • 2016
              • Back
              • Q4 2016
              • Q3 2016
      • Stock Info
      • Analyst Coverage
      • Corporate Governance
      • Contact Us
  • News and Media
      • Back
      • Podcasts
      • Media Interviews
  • Clinical Trials
      • Back
      • Ongoing Clinical Trials
      • Completed Clinical Trials
      • Clinical Publications
  • Collaborations
      • Back
      • Partnering with AzurRx
  • Contact
      • Back
      • Contact Us
      • Subscribe
  • Home
  • Interviews
Filters
List of articles in category Interviews
Title Date
The Empowered Patient Podcast 15 Feb, 2021
The Richmond Club 20 Jun, 2020
U.S. Biopharmaceuticals 2020 Report 04 Jun, 2020
Stock News Now (SNN) Live 19 May, 2020
Innovators with Jane King (LilaMax Media) 18 May, 2020
SD Torrey Hills Capital 21 Apr, 2020
Proactive Investors 09 Apr, 2020
BioPub video interview with AzurRx CEO James Sapirstein and Chief Medical Officer James Pennington 20 Mar, 2020
  • About
  • Science & Technology
  • Investors
  • News and Media
  • Clinical Trials
  • Collaborations
  • Contact

Contact Us

AzurRx BioPharma, Inc.

1615 South Congress Avenue
Suite 103
Delray Beach, Florida 33445 

Tel: 646-699-7855
info@azurrx.com

AzurRx SAS

Jardin des Entreprises, Bat 1
290, Chemin de Saint-Dionisy
30980 Langlade, France

Tel: +33 (0)4 66 67 08 16

SiteMap Ⓒ 2021 AzurRx All Rights Reserved.